Smith C J, Marnett L J
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Arch Biochem Biophys. 1996 Nov 15;335(2):342-50. doi: 10.1006/abbi.1996.0515.
Previous studies have demonstrated that mutation in prostaglandin endoperoxide synthase-1 of Cys313 or Cys540 to Ser residues reduces cyclooxygenase and peroxidase activities by 80-90%. In the present work, we investigated the effect of these Cys-to-Ser mutations on the sensitivity of the enzyme to inhibition by cyclooxygenase inhibitors, the ability of the enzyme to form homodimers, the extent of glycosylation of the enzyme, and the sensitivity of the enzyme to maleimide enzyme inhibitors. No significant differences were observed between native and mutant enzymes in any of these parameters. The results suggest that the loss of activity observed in the mutant enzymes is not due to major differences in protein folding or aggregation. Most surprising was the finding that the sensitivity of prostaglandin H synthase-1 to maleimide-containing inhibitors was not affected by mutating any of the Cys to Ser. This indicates that the inhibition of cyclooxygenase activity affected by N-ethylmaleimide and N-carboxyheptylmaleimide is not due to modification of a cysteine residue.
先前的研究表明,前列腺素内过氧化物合酶-1中半胱氨酸313或半胱氨酸540突变为丝氨酸残基会使环氧化酶和过氧化物酶活性降低80-90%。在本研究中,我们研究了这些半胱氨酸到丝氨酸突变对该酶对环氧化酶抑制剂抑制作用的敏感性、该酶形成同型二聚体的能力、该酶的糖基化程度以及该酶对马来酰亚胺酶抑制剂的敏感性的影响。在这些参数中的任何一个方面,天然酶和突变酶之间均未观察到显著差异。结果表明,在突变酶中观察到的活性丧失并非由于蛋白质折叠或聚集的重大差异所致。最令人惊讶的是,前列腺素H合酶-1对含马来酰亚胺抑制剂的敏感性不会因将任何半胱氨酸突变为丝氨酸而受到影响。这表明N-乙基马来酰亚胺和N-羧基庚基马来酰亚胺对环氧化酶活性的抑制作用并非由于半胱氨酸残基的修饰。